Variant report

Variant	nsv442241
Chromosome Location	chr11:104950424-104972558
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr11:104970890-104971077	GM12878	blood:	n/a	n/a
2	CEBPB	chr11:104951117-104951358	IMR90	lung:	n/a	n/a
3	CEBPB	chr11:104951169-104951316	Hela-S3	cervix:	n/a	n/a
4	CTCF	chr11:104963760-104963910	HPAF	blood vessel:	n/a	n/a
5	CTCF	chr11:104965975-104966006	GM20000	blood:	n/a	n/a
6	CTCF	chr11:104971768-104971837	GM10266	blood:	n/a	n/a
7	CTCF	chr11:104963680-104963830	HMEC	breast:	n/a	n/a
8	CTCF	chr11:104963580-104963730	HMEC	breast:	n/a	n/a
9	FOS	chr11:104963677-104964022	HUVEC	blood vessel:	n/a	chr11:104963836-104963847 chr11:104963838-104963845 chr11:104963838-104963846 chr11:104963838-104963847 chr11:104963837-104963846
10	FOS	chr11:104970874-104971326	HUVEC	blood vessel:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
11	FOS	chr11:104971940-104972376	MCF10A-Er-Src	breast:	n/a	n/a
12	FOS	chr11:104970870-104971415	MCF10A-Er-Src	breast:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
13	FOS	chr11:104963328-104963986	MCF10A-Er-Src	breast:	n/a	chr11:104963836-104963847 chr11:104963362-104963369 chr11:104963838-104963845 chr11:104963838-104963846 chr11:104963838-104963847 chr11:104963837-104963846
14	FOS	chr11:104970836-104971491	MCF10A-Er-Src	breast:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
15	FOS	chr11:104972012-104972419	MCF10A-Er-Src	breast:	n/a	n/a
16	FOS	chr11:104970925-104971329	MCF10A-Er-Src	breast:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
17	FOS	chr11:104963304-104963982	MCF10A-Er-Src	breast:	n/a	chr11:104963836-104963847 chr11:104963362-104963369 chr11:104963838-104963845 chr11:104963838-104963846 chr11:104963838-104963847 chr11:104963837-104963846
18	FOS	chr11:104963304-104963925	MCF10A-Er-Src	breast:	n/a	chr11:104963836-104963847 chr11:104963362-104963369 chr11:104963838-104963845 chr11:104963838-104963846 chr11:104963838-104963847 chr11:104963837-104963846
19	FOS	chr11:104971878-104972346	MCF10A-Er-Src	breast:	n/a	chr11:104971936-104971945
20	FOS	chr11:104970835-104971425	MCF10A-Er-Src	breast:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
21	FOS	chr11:104972042-104972303	MCF10A-Er-Src	breast:	n/a	n/a
22	FOXA2	chr11:104960656-104960851	HepG2	liver:	n/a	n/a
23	GATA2	chr11:104970412-104971122	HUVEC	blood vessel:	n/a	chr11:104970654-104970665 chr11:104970652-104970661 chr11:104971022-104971032 chr11:104970575-104970585
24	GATA2	chr11:104963362-104963700	SH-SY5Y	brain:	n/a	chr11:104963445-104963455
25	GATA3	chr11:104963287-104963717	SH-SY5Y	brain:	n/a	chr11:104963445-104963455
26	GATA3	chr11:104963367-104963635	MCF-7	breast:	n/a	chr11:104963445-104963455
27	JUND	chr11:104971147-104971315	H1-hESC	embryonic stem cell:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
28	MAZ	chr11:104963309-104963476	HepG2	liver:	n/a	n/a
29	MYC	chr11:104963252-104963831	MCF10A-Er-Src	breast:	n/a	n/a
30	MYC	chr11:104970915-104971322	MCF10A-Er-Src	breast:	n/a	n/a
31	MYC	chr11:104971795-104972416	MCF10A-Er-Src	breast:	n/a	n/a
32	MYC	chr11:104970534-104970664	HUVEC	blood vessel:	n/a	n/a
33	MYC	chr11:104971999-104972414	MCF10A-Er-Src	breast:	n/a	n/a
34	MYC	chr11:104963215-104963761	MCF10A-Er-Src	breast:	n/a	n/a
35	MYC	chr11:104970971-104971322	MCF10A-Er-Src	breast:	n/a	n/a
36	POLR2A	chr11:104950926-104951391	Hela-S3	cervix:	n/a	n/a
37	POLR2A	chr11:104967616-104967654	MCF10A-Er-Src	breast:	n/a	n/a
38	POLR2A	chr11:104964158-104964302	MCF10A-Er-Src	breast:	n/a	n/a
39	POLR2A	chr11:104950871-104950917	Hela-S3	cervix:	n/a	n/a
40	POLR2A	chr11:104951944-104951960	GM12878	blood:	n/a	n/a
41	POLR2A	chr11:104971978-104972500	MCF10A-Er-Src	breast:	n/a	n/a
42	POLR2A	chr11:104961423-104961754	MCF10A-Er-Src	breast:	n/a	n/a
43	POLR2A	chr11:104967904-104967907	MCF10A-Er-Src	breast:	n/a	n/a
44	POLR2A	chr11:104968069-104968173	MCF10A-Er-Src	breast:	n/a	n/a
45	POLR2A	chr11:104965649-104965802	MCF10A-Er-Src	breast:	n/a	n/a
46	POLR2A	chr11:104951882-104951942	GM12878	blood:	n/a	n/a
47	POLR2A	chr11:104964809-104964813	MCF10A-Er-Src	breast:	n/a	n/a
48	POLR2A	chr11:104971071-104971566	MCF10A-Er-Src	breast:	n/a	n/a
49	POLR2A	chr11:104963589-104964054	MCF10A-Er-Src	breast:	n/a	n/a
50	POLR2A	chr11:104960506-104960630	MCF10A-Er-Src	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:104972135-104972185	AG04449	skin:	fetal
2	chr11:104966249-104966299	NT2-D1	testis:	n/a
3	chr11:104972474-104972524	HEK293	kidney:	embryo
4	chr11:104972135-104972185	MCF10A-Er-Src	breast:	n/a
5	chr11:104972135-104972185	Hela-S3	cervix:	n/a
6	chr11:104972135-104972185	LNCaP	prostate:	n/a
7	chr11:104966249-104966299	GM12891	blood:	n/a
8	chr11:104972078-104972128	HEK293	kidney:	embryo
9	chr11:104972078-104972128	ProgFib	skin:	n/a
10	chr11:104972474-104972524	GM06990	blood:	n/a
11	chr11:104966249-104966299	HRCEpiC	kidney:	n/a
12	chr11:104966249-104966299	ProgFib	skin:	n/a
13	chr11:104966249-104966299	HAEpiC	amniotic membrane:	n/a
14	chr11:104972474-104972524	HCF	heart:	n/a
15	chr11:104972135-104972185	A549	lung:	n/a
16	chr11:104972078-104972128	HCF	heart:	n/a
17	chr11:104972078-104972128	NT2-D1	testis:	n/a
18	chr11:104972078-104972128	ovcar-3	ovarian:	n/a
19	chr11:104972135-104972185	NH-A	brain:	n/a
20	chr11:104966249-104966299	HL-60	blood:	n/a
21	chr11:104972078-104972128	NHDF-neo	bronchial:	n/a
22	chr11:104972474-104972524	Hepatocyte	liver:	n/a
23	chr11:104966249-104966299	HRPEpiC	eye:	n/a
24	chr11:104972474-104972524	HNPCEpiC	eye:	n/a
25	chr11:104972078-104972128	U87	brain:	n/a
26	chr11:104972474-104972524	HCPEpiC	choroid plexus:	n/a
27	chr11:104972474-104972524	HIPEpiC	eye:	n/a
28	chr11:104972474-104972524	PrEC	prostate:	n/a
29	chr11:104972078-104972128	PFSK-1	brain:	n/a
30	chr11:104966249-104966299	GM06990	blood:	n/a
31	chr11:104972078-104972128	HMEC	breast:	n/a
32	chr11:104972078-104972128	NHBE	bronchial:	n/a
33	chr11:104972474-104972524	AG04450	lung:	fetal
34	chr11:104972474-104972524	HCT-116	colon:	n/a
35	chr11:104966249-104966299	ovcar-3	ovarian:	n/a
36	chr11:104972474-104972524	GM12878	blood:	n/a
37	chr11:104972135-104972185	MCF-7	breast:	n/a
38	chr11:104972078-104972128	HRPEpiC	eye:	n/a
39	chr11:104972078-104972128	HCT-116	colon:	n/a
40	chr11:104972474-104972524	HPAEpiC	pulmonary alveolar:	n/a
41	chr11:104966249-104966299	PFSK-1	brain:	n/a
42	chr11:104966249-104966299	SKMC	muscle:	n/a
43	chr11:104972135-104972185	AG09309	skin:	n/a
44	chr11:104972078-104972128	HIPEpiC	eye:	n/a
45	chr11:104972474-104972524	T-47D	breast:	n/a
46	chr11:104972474-104972524	NHBE	bronchial:	n/a
47	chr11:104972474-104972524	SK-N-MC	brain:	n/a
48	chr11:104972135-104972185	HRPEpiC	eye:	n/a
49	chr11:104972474-104972524	LNCaP	prostate:	n/a
50	chr11:104972474-104972524	MCF-7	breast:	n/a

Variant related genes	Relation type
CASP1	TF binding region
CARD16	TF binding region
CARD17	TF binding region
CASP1	CpG island
CARD16	CpG island
CARD17	CpG island

Extended variants
information (count: 772 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:772 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs184307404	chr11:104950427-104950428	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs573960174	chr11:104950443-104950444	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs559041264	chr11:104950478-104950479	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs371304046	chr11:104950482-104950483	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs386757118	chr11:104950494-104950495	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs481926	chr11:104950495-104950496	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
7	rs554418834	chr11:104950497-104950498	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs1818162	chr11:104950533-104950534	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs539913902	chr11:104950534-104950535	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs376094250	chr11:104950578-104950579	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs368942591	chr11:104950586-104950587	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs576404608	chr11:104950600-104950601	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs545338986	chr11:104950607-104950608	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs565225981	chr11:104950625-104950626	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs113554395	chr11:104950641-104950642	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs544795086	chr11:104950643-104950644	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs147670403	chr11:104950661-104950662	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs1827526	chr11:104950681-104950682	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs475266	chr11:104950711-104950712	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs546765509	chr11:104950722-104950723	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs188859903	chr11:104950750-104950751	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs150281139	chr11:104950751-104950752	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs1827527	chr11:104950782-104950783	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs565156900	chr11:104950817-104950818	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs1827528	chr11:104950825-104950826	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs1827529	chr11:104950828-104950829	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs569174847	chr11:104950867-104950868	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs193280448	chr11:104950870-104950871	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs548379711	chr11:104950879-104950880	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs377182822	chr11:104950881-104950882	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs184840334	chr11:104950902-104950903	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs72986786	chr11:104950920-104950921	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs553580150	chr11:104950951-104950952	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs189224183	chr11:104950972-104950973	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs539054264	chr11:104950983-104950984	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs555695017	chr11:104950985-104950986	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs575556255	chr11:104950996-104950997	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs138934840	chr11:104951003-104951004	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs561566106	chr11:104951005-104951006	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs547691837	chr11:104951019-104951020	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs574912939	chr11:104951028-104951029	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs181581559	chr11:104951040-104951041	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs560559522	chr11:104951052-104951053	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs117498439	chr11:104951064-104951065	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs114813141	chr11:104951066-104951067	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs562835841	chr11:104951121-104951122	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs374643004	chr11:104951134-104951135	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs531666226	chr11:104951153-104951154	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs548166422	chr11:104951234-104951235	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs149410850	chr11:104951257-104951258	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Cervical cancer	21062161	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	22429812	CNVD
Breast cancer	16608533	CNVD
T-cell lymphomas	19863542	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16785998	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21958427	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17603634	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Basal cell lymphoma	16790693	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Mental retardation	19966786	CNVD
Non-small cell lung cancer	21829676	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Intracranial aneurysm	16715129	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Urothelial carcinoma	21177765	CNVD
Myelofibrosis	22110671	CNVD
Ovarian cancer	21720365	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Glioblastoma multiforme	22286061	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Neuroblastoma	17327916	CNVD
Melanoma	17363583	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Mantle cell lymphoma	19029149	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant melanoma	17260012	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Prostate cancer	16573809	CNVD
Obesity	19966786	CNVD
Prostate cancer	18632612	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:191 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:104945400-104950800	Weak transcription	HUVEC	blood vessel
2	chr11:104948000-104953200	Enhancers	Breast Myoepithelial Primary Cells	Breast
3	chr11:104949200-104951000	Weak transcription	Adipose Nuclei	Adipose
4	chr11:104949400-104950800	Weak transcription	NHEK	skin
5	chr11:104950200-104950800	Enhancers	Primary monocytes fromperipheralblood	blood
6	chr11:104950200-104951000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
7	chr11:104950200-104953400	Enhancers	Cortex derived primary cultured neurospheres	brain
8	chr11:104950400-104950600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
9	chr11:104950400-104950800	Enhancers	Right Atrium	heart
10	chr11:104950400-104951200	Enhancers	Small Intestine	intestine
11	chr11:104950400-104951400	Enhancers	Primary hematopoietic stem cells short term culture	blood
12	chr11:104950400-104951800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
13	chr11:104950400-104952000	Enhancers	iPS-15b Cell Line	embryonic stem cell
14	chr11:104950400-104952200	Enhancers	iPS-18 Cell Line	embryonic stem cell
15	chr11:104950600-104950800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
16	chr11:104950600-104951000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
17	chr11:104950600-104951800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
18	chr11:104950600-104951800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
19	chr11:104950600-104952400	Enhancers	iPS-20b Cell Line	embryonic stem cell
20	chr11:104950600-104953800	Enhancers	HUES48 Cell Line	embryonic stem cell
21	chr11:104950800-104951000	Enhancers	H1 Cell Line	embryonic stem cell
22	chr11:104950800-104951000	Enhancers	H9 Cell Line	embryonic stem cell
23	chr11:104950800-104951000	Enhancers	HUES64 Cell Line	embryonic stem cell
24	chr11:104950800-104951000	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
25	chr11:104950800-104951000	Enhancers	Duodenum Mucosa	Duodenum
26	chr11:104950800-104951000	Weak transcription	Right Atrium	heart
27	chr11:104950800-104951200	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
28	chr11:104950800-104951200	Enhancers	Primary neutrophils fromperipheralblood	blood
29	chr11:104950800-104951200	Enhancers	Fetal Intestine Large	intestine
30	chr11:104950800-104951200	Enhancers	NHEK	skin
31	chr11:104950800-104951400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr11:104950800-104951600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr11:104950800-104951600	Enhancers	Primary T helper cells PMA-I stimulated	--
34	chr11:104950800-104951600	Active TSS	Rectal Mucosa Donor 29	rectum
35	chr11:104950800-104951800	Active TSS	Duodenum Smooth Muscle	Duodenum
36	chr11:104950800-104951800	Enhancers	Dnd41	blood
37	chr11:104950800-104951800	Enhancers	HUVEC	blood vessel
38	chr11:104950800-104952200	Enhancers	Fetal Intestine Small	intestine
39	chr11:104950800-104953000	Enhancers	HUES6 Cell Line	embryonic stem cell
40	chr11:104951000-104951200	Flanking Active TSS	Adipose Nuclei	Adipose
41	chr11:104951000-104951200	Flanking Active TSS	Duodenum Mucosa	Duodenum
42	chr11:104951000-104951400	Enhancers	Primary hematopoietic stem cells	blood
43	chr11:104951000-104951400	Active TSS	Brain Anterior Caudate	brain
44	chr11:104951000-104951400	Active TSS	Right Atrium	heart
45	chr11:104951000-104951600	Weak transcription	H9 Cell Line	embryonic stem cell
46	chr11:104951000-104951600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr11:104951000-104951800	Weak transcription	HUES64 Cell Line	embryonic stem cell
48	chr11:104951000-104952000	Weak transcription	H1 Cell Line	embryonic stem cell
49	chr11:104951000-104952200	Enhancers	ES-I3 Cell Line	embryonic stem cell
50	chr11:104951000-104953600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links